Financials
- Market Capitalization 6.09 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.97
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1150 | LGND Ligand Pharmaceuticals Incorporated - Common Stock | 311.13 USD | +3.09% | +0.56% | +9.20% | +66.27% | 6.20 B USD | ||
| 1153 | RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 89.82 USD | -1.06% | -4.92% | -15.11% | -18.57% | 6.18 B USD | ||
| 1222 | MIRM Mirum Pharmaceuticals, Inc. - common stock | 86.06 USD | +0.06% | +5.03% | -12.51% | +22.71% | 5.59 B USD | ||
| 1247 | ERAS Erasca, Inc. - Common Stock | 15.46 USD | -3.56% | +4.88% | -3.19% | +557.87% | 5.41 B USD |